The Shotlee Journal
Browse Shotlee articles about GLP-1 Medications.
Showing 9 / 934 GLP-1 Medications articles
A recent report highlights the increasing use of GLP-1 medications like Ozempic and Mounjaro across the United States, with some states showing greater adoption than others. The data suggests a correlation between obesity rates and GLP-1 prescription rates, particularly in the South and Midwest.
Weight-loss medications are causing a recognizable 'Ozempic face,' characterized by gauntness and premature aging. Skincare brands are formulating serums to counteract these effects, but dermatologists are divided on their necessity and efficacy. Experts emphasize distinguishing science-based solutions from marketing.
This article explores the potential effects of Ozempic on bone health during weight loss. While Ozempic itself may not directly cause bone loss, the weight loss it induces can affect bone density. Learn how to protect your bones with proper nutrition and exercise.
This article examines the emerging trend of microdosing GLP-1 medications like Mounjaro for various health conditions. It delves into personal experiences, potential benefits, and expert warnings regarding unsupervised use.
The GLP-1 weight loss market is experiencing significant shifts with new leadership and competitive pressures. This article dives into the latest developments surrounding semaglutide, Ozempic, and Wegovy, and explores the broader impact on health and wellness.
New data reveals a drop in US obesity rates, and GLP-1 drugs like Ozempic and Wegovy are likely playing a significant role. This post explores the impact of these medications and what it means for your health.
The market for GLP-1 weight loss medications is booming, but it's also highly competitive. This post explores the latest developments, including legal battles and the future of these groundbreaking treatments, and how it impacts your health journey.
Eli Lilly's significant investment in Puerto Rico aims to boost the production of oral GLP-1 medications, like orforglipron, for weight loss and other health benefits. This marks a turning point in accessible treatments for metabolic health. Dive into what this means for you and your wellness journey.
The pharmaceutical landscape is shifting. Direct-to-consumer pricing for medications like GLP-1s is gaining traction. This could reshape how we access and afford treatments for weight loss and metabolic health. Learn how this might affect your wellness.
